Merck News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

31.05.15	Tesaro, Merck To Collaborate On Combination Study Of Niraparib, Keytruda (RTTNews)
29.05.15	Amgen & Merck Join To Evaluate Laherparepvec In Combination With KEYTRUDA (RTTNews)
29.05.15	Merck Submits NDA To FDA For Grazoprevir/Elbasvi (RTTNews)
28.05.15	Merck, NanoString Collaborate To Develop Immune-Related Gene Expression Assay (RTTNews)
26.05.15	Merck Reports CHMP Positive Opinion For SIMPONI - Quick Facts (RTTNews)
22.05.15	Merck Gets Positive CHMP Opinion For Skin Cancer Therapy Keytruda (RTTNews)
12.05.15	New Vaccine Could Prevent 80% Of Cervical Cancers (RTTNews)
28.04.15	Merck Tops Estimates, Boosts Outlook (RTTNews)
28.04.15	Pre-market Movers For April 28 (AAPL, MRK, PFE, BP, TOT, AET, BMY, F, WHR, COH) (RTTNews)
28.04.15	Merck Q1 Profit Beats Estimates; Updates Full Year Guidance - Quick Facts (RTTNews)
28.04.15	Merck Announces Publication Of Pivotal Data From Phase 3 Studies Of ZERBAXA (RTTNews)
28.04.15	After-market Movers For April 27 (AAPL, MRK, AVB, RTEC, RCII, TCS, AMKR, OLN) (RTTNews)
28.04.15	Merck: Januvia Heart Safety Trial Meets Primary Endpoint (RTTNews)
24.04.15	Merck Says Phase 3 C-EDGE Trial Shows High Sustained Virologic Responses (RTTNews)
23.04.15	Merck Announces Results From C-SURFER Phase 2/3 Clinical Trial - Quick Facts (RTTNews)
21.04.15	Merck To Present More Than 30 Data Presentations On Anti-infective Medicines (RTTNews)
20.04.15	TetraLogic And Merck Enter Into Oncology Clinical Study Collaboration (RTTNews)
20.04.15	ATHX Suffers Another Blow, MRK's Keytruda Proven Superior, TROV Outperforms (RTTNews)
19.04.15	Merck: KEYTRUDA Found Superior To Ipilimumab In Advanced Melanoma Phase 3 Study (RTTNews)
19.04.15	Merck Submits SBLA For KEYTRUDA In Advanced Non-Small Cell Lung Cancer (RTTNews)
15.04.15	MRK, NLNK Strive For Ebola Shot, VCYT Cuts A Deal, EVOK Hits Milestone (RTTNews)
08.04.15	Advaxis, Merck Announce Initiation Of Enrollment In Phase 1/2 Study Of ADXS-PSA (RTTNews)
08.04.15	Merck Says Grazoprevir/Elbasvir Gets Two FDA Breakthrough Therapy Designations (RTTNews)
31.03.15	Syndax Pharma & Merck Enter Clinical Trial Collaboration - Quick Facts (RTTNews)
31.03.15	Did You Ride The Rally In These Stocks? (RTTNews)
26.03.15	Ablynx And Merck Extend Ion Channel Research Collaboration - Quick Facts (RTTNews)
24.03.15	Merck To Buyback $10 Bln Stock (RTTNews)
24.03.15	Merck: KEYTRUDA Showed Superior Overall Survival Vs. Ipilimumab In Phase 3 Study (RTTNews)
14.03.15	Merck Says FDA Cancels Panel's Meeting To Review Sugammadex (RTTNews)
11.03.15	KEYTRUDA To Be Made Available To Patients Via U.K. EAMS For Advanced Melanoma (RTTNews)
10.03.15	Merck Slapped With Lawsuit Over Suicide Allegedly Linked To Hair Loss Drug (RTTNews)
05.03.15	Merck Records Positive Results In Two Post-hoc Trials Of Zontivity (RTTNews)
25.02.15	Merck To Present New Data From IMPROVE-IT Study Of VYTORIN (RTTNews)
23.02.15	NGM And Merck Collaborate On Novel Biologic Therapeutics - Quick Facts (RTTNews)
06.02.15	Merck Prices $8.0 Bln Offering Of Senior Unsecured Notes - Quick Facts (RTTNews)
04.02.15	Merck Q4 Profit Beats View, But Outlook Disappoints (RTTNews)
04.02.15	Merck Q4 Profit Surges On One-time Gain, Tops Estimates - Quick Facts (RTTNews)
04.02.15	AMGN's Biosimilar Matches Blockbuster, PFE Gets FDA Nod, LGND Does A Deal (RTTNews)
03.02.15	Merck's Insomnia Medicine BELSOMRA Now Available In U.S. - Quick Facts (RTTNews)
02.02.15	Merck Repatriates Diabetes And Thyroids Portfolio In Russia - Quick Facts (RTTNews)
26.01.15	Merck : CHMP Issues Positive Opinion For Investigational Antibiotic SIVEXTRO (RTTNews)
21.01.15	Merck Closes Tender Offer To Buy Cubist Pharma - Quick Facts (RTTNews)
14.01.15	LLY Collaborates With BMY And MRK, CLTX On Watchlist, ZLTQ Continues To Grow (RTTNews)
13.01.15	Merck, Eli Lilly In Oncology Clinical Trial Collaboration - Quick Facts (RTTNews)
12.01.15	Merck Issues Update On Strategic Actions - Quick Facts (RTTNews)
19.12.14	Merck Commences Tender Offer To Acquire Cubist Pharma - Quick Facts (RTTNews)
18.12.14	Merck Acquires OncoEthix For $110 Mln Plus Milestone Payments - Quick Facts (RTTNews)
11.12.14	Will The New HPV Vaccine Prove A Shot In The Arm For Merck? (RTTNews)
10.12.14	Merck Presents Data On KEYTRUDA In Advanced Triple-Negative Breast Cancer (RTTNews)
09.12.14	Merck Committed To Cubist Pharma Acquisition Despite Patent Ruling (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

19.11.24		Schwacher Handel: Dow Jones beendet den Dienstagshandel mit Verlusten
19.11.24		Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus
19.11.24		Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein
19.11.24		Gewinne in New York: NASDAQ 100 legt zu
19.11.24		Dow Jones-Handel aktuell: So entwickelt sich der Dow Jones aktuell
19.11.24		Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer
19.11.24		Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich

19.11.24

Schwacher Handel: Dow Jones beendet den Dienstagshandel mit Verlusten

19.11.24

Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus

19.11.24

Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein

19.11.24

Gewinne in New York: NASDAQ 100 legt zu

19.11.24

Dow Jones-Handel aktuell: So entwickelt sich der Dow Jones aktuell

19.11.24

Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer

19.11.24

Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	3’870.00	1.49 %	K V
Lonza Grp	513.60	1.14 %	K V
Swiss Re	125.25	0.20 %	K V
Holcim	88.46	0.11 %	K V
Kuehne+Nagel Int	210.40	0.00 %	K V
Logitech Intl	68.92	-1.20 %	K V
Part Grp Hldg	1’209.00	-1.47 %	K V
CieFinRichemont	118.90	-1.94 %	K V
Nestle	76.66	-1.94 %	K V
Sonova Hldg	300.40	-5.21 %	K V

Nachrichten zu Merck Co.

Aktien Top/Flop

Merck Peer Group Nachrichten

Meistgelesene Nachrichten